ADDY HOEZEE-GIRNUS: Open Payments
NPI 1003520651 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 22 payments from 8 companies in 2025. Trend: 2023 $212 · 2024 $495 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $164 |
| Regeneron Healthcare Solutions, Inc. | 5 | $137 |
| Amgen Inc. | 3 | $61 |
| ABBVIE INC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: COSENTYX, DUPIXENT, OTEZLA, SKYRIZI, SPEVIGO, LIBTAYO, NEMLUVIO, CIBINQO.
Industry payments across AL — which companies pay providers there.
